The estimated Net Worth of Steven B Ratoff is at least $1.14 Milione dollars as of 8 April 2021. Mr. Ratoff owns over 7,020 units of Eagle Pharmaceuticals Inc stock worth over $102,068 and over the last 11 years he sold EGRX stock worth over $750,100. In addition, he makes $286,636 as Independent Director at Eagle Pharmaceuticals Inc.
Sign up
Mr. Ratoff EGRX stock SEC Form 4 insiders trading
Steven has made over 5 trades of the Eagle Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 7,020 units of EGRX stock worth $51,457 on 8 April 2021.
The largest trade he's ever made was selling 10,000 units of Eagle Pharmaceuticals Inc stock on 3 April 2014 worth over $750,100. On average, Steven trades about 1,414 units every 151 days since 2014. As of 8 April 2021 he still owns at least 27,364 units of Eagle Pharmaceuticals Inc stock.
You can see the complete history of Mr. Ratoff stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Steven Ratoff biography
Steven B. Ratoff serves as Independent Director of the Company., since March 2007. Mr. Ratoff has served as the chief executive officer of CM Systems LLC, a cloud based software company, since July 2018. Mr. Ratoff's prior experience includes serving as a venture partner for ProQuest Investments from 2005 to 2013, as chief executive officer of Novadel Pharma, Inc., a specialty pharmaceutical company from 2010 to 2017, and as chief executive officer of CIMA Labs, Inc., a specialty pharmaceutical company acquired by Cephalon in 2004. In addition, Mr. Ratoff served as chief financial officer of the Brown-Forman Company from 1995 to 2001. Mr. Ratoff holds a B.S. in business administration from Boston University and an M.B.A. with Distinction from the University of Michigan. Our Board believes that Mr. Ratoff's extensive executive experience and background in the global pharmaceutical and consumer products industries as well as his strong financial background qualifies him to serve on our Board.
What is the salary of Steven Ratoff?
As the Independent Director of Eagle Pharmaceuticals Inc, the total compensation of Steven Ratoff at Eagle Pharmaceuticals Inc is $286,636. There are 5 executives at Eagle Pharmaceuticals Inc getting paid more, with Scott Tarriff having the highest compensation of $7,883,700.
How old is Steven Ratoff?
Steven Ratoff is 77, he's been the Independent Director of Eagle Pharmaceuticals Inc since 2007. There are no older and 10 younger executives at Eagle Pharmaceuticals Inc.
What's Steven Ratoff's mailing address?
Steven's mailing address filed with the SEC is C/O EAGLE PHARMACEUTICALS, INC., 50 TICE BLVD., SUITE 315, WOODCLIFF LAKE, NJ, 07677.
Insiders trading at Eagle Pharmaceuticals Inc
Over the last 11 years, insiders at Eagle Pharmaceuticals Inc have traded over $188,911,314 worth of Eagle Pharmaceuticals Inc stock and bought 1,029,065 units worth $16,655,732 . The most active insiders traders include Executive Capital Lphec Man..., Douglas L Braunstein e Investments Iv, L.P.Pro Que.... On average, Eagle Pharmaceuticals Inc executives and independent directors trade stock every 43 days with the average trade being worth of $193,721. The most recent stock trade was executed by Scott Tarriff on 1 November 2023, trading 21,619 units of EGRX stock currently worth $299,207.
What does Eagle Pharmaceuticals Inc's logo look like?
Complete history of Mr. Ratoff stock trades at Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals Inc executives and stock owners
Eagle Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Scott Tarriff,
Chief Executive Officer, Director -
David Pernock,
President, Chief Operating Officer -
David M. Pernock,
Exec. VP of Operations -
Brian Joseph Cahill,
Chief Financial Officer -
Michael Graves,
Independent Chairman of the Board -
Steven Ratoff,
Independent Director -
Robert Glenning,
Independent Director -
Jennifer Simpson,
Independent Director -
Richard Edlin,
Independent Director -
Lisa Wilson,
IR Contact Officer -
Brian Cahill,
Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer -
Debra M. Hussain,
Sr. VP & Head of Commercial -
Reiner Nowak,
Exec. -
Dr. Gaozhong Zhu Ph.D.,
Sr. VP of Pharmaceutical Devel. -
Dr. Valentin R. Curt M.D.,
Sr. VP of Clinical Drug Devel. -
John Kimmet,
Exec. VP of Marketing Oncology & Acute Care -
Michael Shawn Moran,
Exec. VP, Chief Commercial Officer & Principal Operating Officer -
Daniel O'Connor,
Exec. VP, Chief Strategy Officer & Head of Corp. Devel. -
Ryan Debski,
Exec. VP, Gen. Counsel & Chief Compliance Officer -
Steven L. Krill,
Chief Scientific Officer -
Pete A. Meyers,
Chief Financial Officer -
David E Riggs,
Chief Financial Officer -
Investments Iv, L.P.Pro Que...,
-
Sander A Flaum,
Director -
Douglas L Braunstein,
Director -
Executive Capital Lphec Man...,
-
Alain Schreiber,
Director -
Jay Moorin,
Director -
Management Llc Pro Quest In...,
-
Financial Llc Pro Quest Inv...,
-
Paul Bruinenberg,
Chief Medical Officer -
Associates Iv Llc Pro Quest...,
-
Judith Ng Cashin,
Chief Medical Officer -
Luciana Borio,
Director -
Michael Shawn Moran,
EVP, Chief Commercial Officer